NASDAQ:ILMN
Illumina Inc
- Stock
Issues Detected
Our system has detected quality issues with this report. The team is informed is working to resolve the issues. Please click the button below to request an expedited investigation.
industry
Diagnostics & Researchexchange
NASDAQ Global Selectwebsite
www.illumina.comipo date
Jul 28, 2000full time employees
11,500currency
USD
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive he...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- David R. Walt
- John Stuelpnagel
- Larry Bock
- Satnam Alag
num employees
- 5001-10000
recent investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
$9M | Series A - Mantra Bio | — | 04-01-2023 | Mantra Bio |
— | Pre Seed Round - Mable (Neurolytic Healthcare) | — | 27-07-2022 | Mable (Neurolytic Healthcare) |
$375M | Post-IPO Equity - SomaLogic | — | 01-09-2021 | SomaLogic |
£499.8K | Pre Seed Round - Concr | — | 01-04-2021 | Concr |
$70M | Series F - Ginkgo Bioworks | — | 28-05-2020 | Ginkgo Bioworks |
$390M | Series D - Grail | — | 06-05-2020 | Grail |
$200M | Venture Round - Helixis | — | 01-03-2018 | Helixis |
$200M | Series B - Helix | — | 01-03-2018 | Helix |
$2.8M | Seed Round - Prospect Bio | — | 15-11-2016 | Prospect Bio |
$2M | Seed Round - Vitagene | No | 17-02-2016 | Vitagene |